Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 29

1.

Microvascular anomaly conditions in psychiatric disease. Schizophrenia - angiogenesis connection.

Katsel P, Roussos P, Pletnikov M, Haroutunian V.

Neurosci Biobehav Rev. 2017 Jun;77:327-339. doi: 10.1016/j.neubiorev.2017.04.003. Epub 2017 Apr 8. Review.

PMID:
28396239
2.

Loss of precuneus dendritic spines immunopositive for spinophilin is related to cognitive impairment in early Alzheimer's disease.

Mi Z, Abrahamson EE, Ryu AY, Fish KN, Sweet RA, Mufson EJ, Ikonomovic MD.

Neurobiol Aging. 2017 Jul;55:159-166. doi: 10.1016/j.neurobiolaging.2017.01.022. Epub 2017 Feb 4.

PMID:
28259365
3.

Patterns of regional gray matter loss at different stages of schizophrenia: A multisite, cross-sectional VBM study in first-episode and chronic illness.

Torres US, Duran FL, Schaufelberger MS, Crippa JA, Louzã MR, Sallet PC, Kanegusuku CY, Elkis H, Gattaz WF, Bassitt DP, Zuardi AW, Hallak JE, Leite CC, Castro CC, Santos AC, Murray RM, Busatto GF.

Neuroimage Clin. 2016 Jun 3;12:1-15. doi: 10.1016/j.nicl.2016.06.002. eCollection 2016.

4.

A Review of Impaired Neuroplasticity in Schizophrenia Investigated with Non-invasive Brain Stimulation.

Bhandari A, Voineskos D, Daskalakis ZJ, Rajji TK, Blumberger DM.

Front Psychiatry. 2016 Mar 29;7:45. doi: 10.3389/fpsyt.2016.00045. eCollection 2016. Review.

5.

NeuN+ neuronal nuclei in non-human primate prefrontal cortex and subcortical white matter after clozapine exposure.

Halene TB, Kozlenkov A, Jiang Y, Mitchell AC, Javidfar B, Dincer A, Park R, Wiseman J, Croxson PL, Giannaris EL, Hof PR, Roussos P, Dracheva S, Hemby SE, Akbarian S.

Schizophr Res. 2016 Feb;170(2-3):235-44. doi: 10.1016/j.schres.2015.12.016. Epub 2016 Jan 6.

6.

Progressive Brain Atrophy and Cortical Thinning in Schizophrenia after Commencing Clozapine Treatment.

Ahmed M, Cannon DM, Scanlon C, Holleran L, Schmidt H, McFarland J, Langan C, McCarthy P, Barker GJ, Hallahan B, McDonald C.

Neuropsychopharmacology. 2015 Sep;40(10):2409-17. doi: 10.1038/npp.2015.90. Epub 2015 Apr 1.

7.

A multimodal analysis of antipsychotic effects on brain structure and function in first-episode schizophrenia.

Lesh TA, Tanase C, Geib BR, Niendam TA, Yoon JH, Minzenberg MJ, Ragland JD, Solomon M, Carter CS.

JAMA Psychiatry. 2015 Mar;72(3):226-34. doi: 10.1001/jamapsychiatry.2014.2178.

8.

Autophagy inhibition uncovers the neurotoxic action of the antipsychotic drug olanzapine.

Vucicevic L, Misirkic-Marjanovic M, Paunovic V, Kravic-Stevovic T, Martinovic T, Ciric D, Maric N, Petricevic S, Harhaji-Trajkovic L, Bumbasirevic V, Trajkovic V.

Autophagy. 2014;10(12):2362-78. doi: 10.4161/15548627.2014.984270.

9.

How should we intervene in psychosis risk syndromes?

Wang J, Jiang K, Zhang T, Li H, Woodberry K, Seidman L.

Shanghai Arch Psychiatry. 2013 Feb;25(1):6-9. doi: 10.3969/j.issn.1002-0829.2013.01.003. Review.

10.

Neuroprogressive effects of lifetime illness duration in older adults with bipolar disorder.

Gildengers AG, Chung KH, Huang SH, Begley A, Aizenstein HJ, Tsai SY.

Bipolar Disord. 2014 Sep;16(6):617-23. doi: 10.1111/bdi.12204. Epub 2014 Apr 10.

11.

Relapse duration, treatment intensity, and brain tissue loss in schizophrenia: a prospective longitudinal MRI study.

Andreasen NC, Liu D, Ziebell S, Vora A, Ho BC.

Am J Psychiatry. 2013 Jun;170(6):609-15. doi: 10.1176/appi.ajp.2013.12050674. Erratum in: Am J Psychiatry. 2013 Jun 1;170(6):689.

12.

Anatomical abnormalities in gray and white matter of the cortical surface in persons with schizophrenia.

Colibazzi T, Wexler BE, Bansal R, Hao X, Liu J, Sanchez-Peña J, Corcoran C, Lieberman JA, Peterson BS.

PLoS One. 2013;8(2):e55783. doi: 10.1371/journal.pone.0055783. Epub 2013 Feb 13.

13.

Psychotic symptoms and gray matter deficits in clinical pediatric populations.

Gogtay N, Weisinger B, Bakalar JL, Stidd R, Fernandez de la Vega O, Miller R, Clasen L, Greenstein D, Rapoport JL.

Schizophr Res. 2012 Sep;140(1-3):149-54. doi: 10.1016/j.schres.2012.07.006. Epub 2012 Jul 24.

14.

Decrease in temporal gyrus gray matter volume in first-episode, early onset schizophrenia: an MRI study.

Tang J, Liao Y, Zhou B, Tan C, Liu W, Wang D, Liu T, Hao W, Tan L, Chen X.

PLoS One. 2012;7(7):e40247. doi: 10.1371/journal.pone.0040247. Epub 2012 Jul 3.

15.

Stereological analysis of neuron, glial and endothelial cell numbers in the human amygdaloid complex.

García-Amado M, Prensa L.

PLoS One. 2012;7(6):e38692. doi: 10.1371/journal.pone.0038692. Epub 2012 Jun 13. Erratum in: PLoS One. 2012; 7(11). doi:10.1371/annotation/42d5754a-295b-466e-ae55-6f9f41b06760.

16.

Progressive brain change in schizophrenia: a prospective longitudinal study of first-episode schizophrenia.

Andreasen NC, Nopoulos P, Magnotta V, Pierson R, Ziebell S, Ho BC.

Biol Psychiatry. 2011 Oct 1;70(7):672-9. doi: 10.1016/j.biopsych.2011.05.017. Epub 2011 Jul 23.

17.

Stereological analysis of the rat and monkey amygdala.

Chareyron LJ, Banta Lavenex P, Amaral DG, Lavenex P.

J Comp Neurol. 2011 Nov 1;519(16):3218-39. doi: 10.1002/cne.22677.

18.

Long-term antipsychotic treatment and brain volumes: a longitudinal study of first-episode schizophrenia.

Ho BC, Andreasen NC, Ziebell S, Pierson R, Magnotta V.

Arch Gen Psychiatry. 2011 Feb;68(2):128-37. doi: 10.1001/archgenpsychiatry.2010.199.

19.

The treatment of cognitive impairment in schizophrenia.

Goff DC, Hill M, Barch D.

Pharmacol Biochem Behav. 2011 Aug;99(2):245-53. doi: 10.1016/j.pbb.2010.11.009. Epub 2010 Nov 27. Review.

20.

Stereological approaches to identifying neuropathology in psychosis.

Dorph-Petersen KA, Lewis DA.

Biol Psychiatry. 2011 Jan 15;69(2):113-26. doi: 10.1016/j.biopsych.2010.04.030. Epub 2010 Aug 1. Review.

Supplemental Content

Support Center